文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

脓毒性休克相关急性肾损伤的流行病学:一项全国性回顾性队列研究

Epidemiology of Septic Shock Associated Acute Kidney Injury: A National Retrospective Cohort Study.
PubMed 文献 · Crit Care Med · 2025-06-13
一句话结论住院脓毒性休克患者中92.8%发生急性肾损伤,3期急性肾损伤与院内死亡风险最高相关(OR 1.66)。

该回顾性多中心队列研究纳入美国220家社区与教学医院中入院时诊断脓毒性休克的成年患者共21,803例,评估急性肾损伤分期、30天主要不良肾脏事件(MAKE-30)及肾脏替代治疗(RRT)使用情况。结果显示92.8%的患者住院期间发生急性肾损伤,其中1期22.9%、2期27.3%、3期42.7%;6.4%接受RRT,MAKE-30发生率为42.0%,30.9%死亡。1期急性肾损伤与死亡率无显著关联(OR 1.12,95%CI 0.97-1.29),2期(OR 1.25,95%CI 1.09-1.43)和3期(OR 1.66,95%CI 1.46-1.89)与死亡率显著相关。

要点

  • 脓毒性休克住院患者中92.8%发生急性肾损伤,3期占42.7%。
  • 3期急性肾损伤与院内死亡风险显著相关(OR 1.66,95%CI 1.46-1.89,p<0.001)。
  • 2期急性肾损伤亦与死亡显著相关(OR 1.25,95%CI 1.09-1.43,p=0.001),1期无显著关联(OR 1.12,95%CI 0.97-1.29,p=0.109)。
  • 6.4%的患者接受肾脏替代治疗,MAKE-30发生率为42.0%,30.9%死亡。

适用人群与场景

  • 美国220家地理分布多样的社区与教学医院中,入院时诊断脓毒性休克的成年患者。

研究设计与关键结果

  • 研究类型为回顾性多中心队列研究,纳入21,803例入院时脓毒性休克的成年患者,来自美国220家社区与教学医院。
  • 患者平均年龄66.0岁(标准差15.1岁),48.6%为女性,29.5%有慢性肾脏病,平均估算肾小球滤过率为35.8 mL/min/1.73 m²(标准差24.3 mL/min/1.73 m²)。
  • 住院期间急性肾损伤最高分期:无7.2%、1期22.9%、2期27.3%、3期42.7%;接受肾脏替代治疗者占6.4%。
  • MAKE-30发生率为42.0%,30.9%死亡。
  • 1期急性肾损伤与死亡率无显著关联(OR 1.12,95%CI 0.97-1.29,p=0.109);2期(OR 1.25,95%CI 1.09-1.43,p=0.001)和3期(OR 1.66,95%CI 1.46-1.89,p<0.001)与死亡率显著相关。

证据类型、等级与局限

  • 证据类型:回顾性多中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Septic shock is the most severe and final stage of sepsis. These patients may have a higher risk for sepsis-associated acute kidney injury (AKI). The purpose of this study is to determine the frequency of AKI, major adverse kidney events at 30 days (MAKE-30), and use of renal replacement therapy (RRT) in patients with septic shock. We also aim to determine the association between stage of AKI and in-hospital mortality.

DESIGN: Retrospective, multicenter, cohort study.

SETTING: This was conducted in 220 geographically diverse community and teaching hospitals across the United States.

PATIENTS: Adult patients were included if they had septic shock on hospital admission.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Measurements include stage 1, 2, and 3 AKI, RRT, and MAKE-30. Of the 21,803 patients included in the final cohort, 92.8% had AKI during hospital admission. Patients had a mean ( sd ) age of 66.0 years (15.1 yr), 48.6% were female, 29.5% had chronic kidney disease, and mean ( sd ) estimated glomerular filtration rate was 35.8 mL/min/1.73 m 2 (24.3 mL/min/1.73 m 2 ). The maximum stage of AKI during hospitalization was none (7.2%), stage 1 (22.9%), stage 2 (27.3%), or stage 3 (42.7%). The proportion of patients who received RRT was 6.4%. MAKE-30 occurred in 42.0% and 30.9% died. There was no significant association between stage 1 (odds ratio [OR], 1.12; 95% CI, 0.97-1.29; p = 0.109), but there was a significant association between stage 2 (OR, 1.25; 95% CI, 1.09-1.43; p = 0.001), and stage 3 AKI (OR, 1.66; 95% CI, 1.46-1.89; p < 0.001) and mortality.

CONCLUSIONS: Among hospitalized patients with septic shock, most patients have AKI, and stage 3 AKI is associated with the highest risk of mortality.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Patanwala AE, Erstad BL. Epidemiology of Septic Shock Associated Acute Kidney Injury: A National Retrospective Cohort Study. Crit Care Med. 2025. PMID: 40511991. doi:10.1097/CCM.0000000000006735

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。